Abooshahab, Raziyeh, Hani Al-Salami, and Crispin R. Dass. “Targeting Metabolic Vulnerabilities in Breast Cancer Cells by Combining PEDF and Doxorubicin: Pathway Insights from GC MS-Based Metabolomics”. EXCLI Journal 24 (August 18, 2025): 1037–1055. Accessed March 14, 2026. https://www.excli.de/excli/article/view/8508.